Hey, this is AUStock_Pedia.
I would like to introduce some Australian companies that may be of some help to your investments.
The company I'm going to introduce is Microba Life Sciences Limited$Microba Life Sciences Limited(MAP.AU)$ .
It went public on Apr 5, 2022, and began trading on Australia’s ASX under the ticker symbol "MAP".
[Company Profile]
Microba Life Sciences Limited provides microbiome testing and analysis services for clinicians, consumers, and research customers in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, and the United States. The company was incorporated in 2017 and is based in Brisbane, Australia.
The company offers pathology, therapeutics, and diagnostics services based on the human gut microbiome; Databank, for discovery of therapeutic leads, consumer health innovations, and diagnostic biomarkers; and data-driven therapeutics platform that develops novel monoclonal microbial cell therapies for inflammatory bowel disease, cancer immunotherapy, and autoimmune diseases.
[History & Events]
In 2017, Microba Life Sciences was incorporated in Brisbane, Australia.
In 2018, Microba Life Sciences raised $7,000,000 / Series A from Alium Capital.
In 2019, Microba Life Sciences raised A$4,100,000 / Corporate Round from Microgen Plc.
In 2019, Microba and Google Cloud use innovation and AI to level up gut microbiome testing.
In 2022, Microba Life Sciences went public and began trading on Australia’s ASX under the ticker symbol "MAP".
In 2022, Microba Life Sciences Signs Partnership With Nib-Backed Midnight Health.
In 2022, Microba Life Sciences raised A$17,800,000 / Post Ipo Equity from Sonic Healthcare.
In 2022, Sonic Healthcare Acquires Strategic Stake in Microba Life Sciences, Establishes Significant Commercial Partnership.
[Main Business Segments]
[Net Income & Total Revenue]
Comments